Podofilox Topical Gel — FDA Drug Shortage

To Be Discontinued — AbbVie Inc.

The FDA lists a drug shortage record for Podofilox Topical Gel (topical gel) from AbbVie Inc. with status To Be Discontinued. The shortage was first posted on Jan 28, 2026.

Shortage details

Status
To Be Discontinued
Company
AbbVie Inc.
Package NDC
0023-6118-03
Dosage Form
Topical Gel
Presentation
Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)
Initial Posting
Jan 28, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.